ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
3,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4,1,Urine abnormality,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
5,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
7,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
8,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
9,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
9,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9,3,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
10,1,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
11,1,Conjunctival disorder,"Conjunctival structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
12,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
13,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
14,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
14,2,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
15,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
16,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
17,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
17,2,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
17,3,Retinal scar,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
17,4,Symblepharon,"Conjunctival structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
18,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
19,1,Accommodation disorder,Refractive and accommodative disorders,Vision disorders,Eye,N
19,2,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
19,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
19,4,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
20,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
20,2,Headache,Headaches NEC,Headaches,Nerv,N
21,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
22,1,Headache,Headaches NEC,Headaches,Nerv,N
23,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
24,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
24,2,Retinal vascular disorder,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
25,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
26,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
26,2,Headache,Headaches NEC,Headaches,Nerv,N
26,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
26,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
27,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
28,1,Xerophthalmia,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
29,1,Headache,Headaches NEC,Headaches,Nerv,N
30,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
31,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
32,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
33,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
34,1,Headache,Headaches NEC,Headaches,Nerv,N
35,1,Headache,Headaches NEC,Headaches,Nerv,N
35,2,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
35,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
35,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
36,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
37,1,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
38,1,Headache,Headaches NEC,Headaches,Nerv,N
39,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
40,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
40,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
41,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
42,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
43,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
43,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
44,1,Blepharitis,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
45,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
46,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
47,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
47,2,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
47,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
48,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
49,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
50,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
50,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
51,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
52,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
53,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
54,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
55,1,Iron metabolism disorder,Iron metabolism disorders NEC,Iron and trace metal metabolism disorders,Metab,N
56,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
57,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
57,2,Corneal opacity,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
58,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
59,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
60,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
61,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
62,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
62,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
63,1,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
63,2,Trichiasis,"Lid, lash and lacrimal structural disorders","Anterior eye structural change, deposit and degeneration",Eye,N
64,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
64,2,Corneal scar,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
64,3,Symblepharon,"Conjunctival structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
65,1,Sarcoma,Soft tissue sarcomas histology unspecified,Soft tissue neoplasms malignant and unspecified,Neopl,N
